Sirona Biochem Announces Addition of Dr. Brett Premack as Scientific Consultant
News Mar 15, 2012
Sirona Biochem Corp. has announced the appointment of Dr. Brett Premack as Scientific Consultant.
Dr. Premack will consult and advise on preclinical development activities, particularly pertaining to alliances between public and private research organizations.
"Dr. Brett Premack's expertise in drug discovery and preclinical development will bring tremendous value in the evaluation and development of our therapeutic portfolio," said Dr. Howard Verrico, President & CEO of Sirona Biochem.
"Our chemistry platform technology gives us several program options and our ability to attract high-calibre talent like Dr. Premack enables us to efficiently advance these programs," Dr. Verrico added.
Targeted Drug Could be Used to Treat Advanced Cancers Located Anywhere in the BodyNews
A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body.READ MORE
Human Malaria Parasites Grown for the First Time in Dormant FormNews
One of the biggest obstacles to eradicating malaria is a dormant form of the parasite which is resistant to most antimalarial drugs and can reawaken years later, causing disease relapse. Researchers have shown they can grow the dormant parasite in engineered human liver tissue for several weeks, allowing them to closely study how the parasite becomes dormant, what vulnerabilities it may have, and how it springs back to life.READ MORE
Bacteria Produce More Substances Than Genetics PredictedNews
Tandem mass spectrometry has revealed that Streptomyces chartreusis, an antibiotic-producing bacterium, releases more metabolites into the surrounding medium than scientists assumed based on the analysis of the genome. They might include molecules that are of interest as potential pharmaceutical agents.READ MORE